Phase II Trial of Afatinib in Patients With EGFR-Mutated Solid Tumors Excluding Lung Cancer: Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol A.
Gettinger SN, Song Z, Reckamp KL, Moscow JA, Gray RJ, Wang V, McShane LM, Rubinstein LV, Patton DR, Williams PM, Hamilton SR, Kong XT, Tricoli JV, Conley BA, Arteaga CL, Harris LN, O'Dwyer PJ, Chen AP, Flaherty KT.
Gettinger SN, et al. Among authors: kong xt.
JCO Precis Oncol. 2024 Jul;8:e2300725. doi: 10.1200/PO.23.00725.
JCO Precis Oncol. 2024.
PMID: 38986051
Clinical Trial.